In breast cancer, the elevated expression of Akt causes normal breast cells to become neoplasm cells via the dysregulation of the cyclin-dependent kinase (CDK) inhibitor, p2122, and inactivation or mutant to tumor suppressor, p53 protein so that the replication of abnormal DNA is not stopped23. This evidence concerns the gene TP53 and breast cancer.